ANTXR2 and prostate carcinoma: For example, while CMG2 was shown to regulate prostate cancer cell adhesion and invasiveness [40], in breast cancer, CMG2 inhibited breast cancer cell growth and was inversely correlated with disease progression and prognosis [41].